1.武汉科技大学附属天佑医院神经外科,湖北 武汉 430064
2.新疆医科大学研究生院,新疆 乌鲁木齐 830017
3.华中科技大学同济医学院附属同济医院神经外科,湖北 武汉 430030
Published:25 September 2023,
Received:08 December 2022,
扫 描 看 全 文
郐国虎,蒋伟.血清S100B联合神经元特异性烯醇化酶检测在高血压脑出血中的临床应用[J].局解手术学杂志,2023,32(09):830-833.
KUAI Guo-hu,JIANG Wei.Clinical application of serum S100B combined with neuron specific enolase detection in hypertensive intracerebral hemorrhage[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(09):830-833.
郐国虎,蒋伟.血清S100B联合神经元特异性烯醇化酶检测在高血压脑出血中的临床应用[J].局解手术学杂志,2023,32(09):830-833. DOI: 10.11659/jjssx.12E022055.
KUAI Guo-hu,JIANG Wei.Clinical application of serum S100B combined with neuron specific enolase detection in hypertensive intracerebral hemorrhage[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(09):830-833. DOI: 10.11659/jjssx.12E022055.
目的
2
探讨血清S100钙结合蛋白B(S100B)联合神经元特异性烯醇化酶(NSE)检测在高血压脑出血(HICH)中的应用效果。
方法
2
选取武汉科技大学附属天佑医院收治的HICH患者50例作为观察组,根据格拉斯哥昏迷量表(GCS)评分将其分为轻度组(GCS评分 13~15分,15例)、中度组(GCS评分 9~12分,19例)和重度组(GCS评分 3~8分,16例)。另选取同期15例健康者作为对照组。随访3个月
根据患者格拉斯哥预后(GOS)评分将患者分为预后良好组27例(GOS评分 4~5分)和预后不良组23例(GOS评分 1~3分)。采用酶联免疫吸附法分别测定S100B和NSE水平,
Spearman
法分析S100B、NSE与预后的相关性。
结果
2
各时间段轻度组、中度组、重度组S100B水平与对照组比较,差异有极显著性统计学意义(
P
<
0.01);各时间段中度组、重度组S100B水平与轻度组比较,差异有统计学意义(
P
<
0.05);入院时、入院24 h及入院48 h,中度组S100B水平与重度组比较,差异有统计学意义(
P
<
0.05)。各时间段轻度组、中度组、重度组NSE水平与对照组比较,差异有极显著性统计学意义(
P
<
0.01);入院48 h及72 h重度组NSE水平与轻度组比较,差异有统计学意义(
P
<
0.05)。
Spearman
相关性分析显示,S100B、NSE水平与HICH患者入院时GCS评分呈负相关(
r
=-0.876、-0.721,
P
<
0.01),与随访3个月时GOS评分呈负相关(
r
=-0.421、-0.309,
P
<
0.05)。预后良好组与预后不良组患者S100B、NSE水平比较,差异有统计学意义(
P
<
0.05)。
结论
2
S100B联合NSE水平用于评估HICH患者疾病严重程度及判定患者预后的效果较好。
Objective
2
To investigate the application effect of serum S100 calcium binding protein B (S100B) combined with neuron specific enolase (NSE) detection in hypertensive intracerebral hemorrhage (HICH).
Methods
2
A total of 50 patients with HICH admitted to Tianyou Hospital Affiliated to Wuhan University of Science and Technology were selected as the observation group. According to Glasgow coma scale (GCS) score, they were divided into the mild group (with GCS score of 13 to 15 points, 15 cases), the moderate group (with GCS score of 9 to 12 points, 19 cases) and the severe group (with GCS score of 3 to 8 points, 16 cases). Another 15 healthy people in the same period were selected as the control group. After 3-month followed-up, according to Glasgow outcome scale (GOS) score, the patients were divided into the good prognosis group (with GOS score of 4 to 5 points, 27 cases) and the poor prognosis group (with GOS score of 1 to 3 points, 23 cases). The levels of S100B and NSE were measured by enzyme-linked immunosorbent assay, and the correlation of S100B and NSE with prognosis was analyzed by
Spearman
method.
Results
2
The S100B levels in the mild group, the moderate group and the severe group in each time period were significantly different from those in the control group (
P
<
0.01). The S100B levels in the moderate group and the severe group were significantly different from that in the mild group (
P
<
0.05). The S100B levels at admission, 24 hours and 48 hours after admission in the moderate group were significantly different from those in the severe group (
P
<
0.05). The NSE levels in the mild group, the moderate group and the severe group in each time period were significantly different from that in the control group (
P
<
0.01). There were statistically significant differences in the NSE levels 48 hours and 72 hours after admission between the severe group and the mild group (
P
<
0.05).
Spearman
correlation analysis showed that S100B and NSE levels were negatively correlated with the GCS score of HICH patients at admission (
r
=-0.876, -0.721;
P
<
0.01), and negatively correlated with the GOS score 3 months after follow-up (
r
=-0.421, -0.309;
P
<
0.05). There were statistically significant differences in the S100B and NSE levels between the good prognosis group and the poor prognosis group (
P
<
0.05).
Conclusion
2
S100B combined with NSE level is effective in assessing the severity of disease and determing the prognosis of HICH patients.
高血压脑出血S100钙结合蛋白B神经元特异性烯醇化酶
hypertensive intracerebral hemorrhageS100 calcium binding protein Bneuron specific enolase
Ferrete-Araujo AM,Rodríguez-Rodríguez A,Egea-Guerrero JJ,et al.Brain injury biomarker behavior in spontaneous intracerebral hemorrhage[J].World Neurosurg,2019,132:e496-e505.doi:10.1016/j.wneu.2019.08.090http://dx.doi.org/10.1016/j.wneu.2019.08.090.
Wu X,Yan T,Wang Z,et al.Role of plasma Apo-J as a biomarker of severity and outcome after intracerebral hemorrhage:a prospective and cohort study[J].Clin Chim Acta,2022,533:148-155.doi:10.1016/j.cca.2022.06.018http://dx.doi.org/10.1016/j.cca.2022.06.018.
Hu Q,Wu X,Wang Z,et al.α-MSH as a potential biomarker of severity and prognosis after intracerebral hemorrhage:a prospective cohort study[J].Clin Chim Acta,2023,538:131-138.doi:10.1016/j.cca.2022.11.004http://dx.doi.org/10.1016/j.cca.2022.11.004.
吴佩涛,杨学,许州,等.颅内压检测及血清HSP70、S100B水平对高血压性脑出血患者预后的预测价值[J].新疆医科大学 学报,2022,45(3):313-317.doi:10.3639/j.issn.1009-5551. 2022.03.015http://dx.doi.org/10.3639/j.issn.1009-5551.2022.03.015.
郐国虎,刘杰,蒋伟.血清相关标记物联合检测在评估颅脑损伤程度及预后中的临床应用[J].局解手术学杂志,2020,29(8):636-639.doi:10.11659/jjssx.05E020132http://dx.doi.org/10.11659/jjssx.05E020132.
中华医学会神经外科学分会,中国医师协会急诊医师分会,中华医学会神经病学分会脑血管病学组,等.高血压性脑出血中国多学科诊治指南[J].中国急救医学,2020,40(8):689-702.doi:10.3969/j.issn.1002-1949.2020.08.001http://dx.doi.org/10.3969/j.issn.1002-1949.2020.08.001.
Cho DY,Chen CC,Lee WY,et al.A new modified intracerebral hemorrhage score for treatment decisions in basal ganglia hemorrhage--a randomized trial[J].Crit Care Med,2008,36:2151-2156.doi:10.1097/CCM.0b013e318173fc99http://dx.doi.org/10.1097/CCM.0b013e318173fc99.
Cui X,Zhou B,Wu J,et al.Changes in amplitude-integrated electroencephalography,neuron-specific enolase,and S100B in neonates with brain injury induced by neonatal hyperbilirubinemia and their significance[J].Brain Inj,2021,35(8):943-948.doi:10.1080/02699052.2021.1931449http://dx.doi.org/10.1080/02699052.2021.1931449.
James ML,Blessing R,Phillips-Butte BG,et al.S100B and brain natriuretic peptide predict functional neurologicaloutcome after intracerebral hemorrhage[J].Biomarkers,2009,14:388-394.doi:10.1080/13547500903015784http://dx.doi.org/10.1080/13547500903015784.
Delgado P,Alvarez Sabin J,Santamarina E,et al.Plasma S100B level after acute spontaneous intracerebral hemorrhage[J].Stroke,2006,37:2837-2839.doi:10.1161/01.STR.0000245085.58807.adhttp://dx.doi.org/10.1161/01.STR.0000245085.58807.ad.
张丽侠,马涛,李荣利.血液中NSE、D-D、Hcy在脑出血病情评估中的价值研究[J].中国急救复苏与灾害医学杂志,2022,17(10):1318-1321.doi:10.3969/j.issn.1673-6966.2022.10.015http://dx.doi.org/10.3969/j.issn.1673-6966.2022.10.015.
DAlatas ÖD,Gürger M,Ateşçelik M,et al.Neuronspecific enolase,S100 calcium-binding protein B and heat shock protein 70 levels in patients with intracranial hemorrhage[J].Medicine (Baltimore),2015,94(45):e2007.doi:10.1097/MD.0000000000002007http://dx.doi.org/10.1097/MD.0000000000002007.
Langeh U,Singh S.Targeting S100B protein as a surrogate biomarker and its role in various neurological disorders[J].Curr Neuropharmacol,2021,19(2):265-277.doi:10.2174/1570159X18666200729100427http://dx.doi.org/10.2174/1570159X18666200729100427.
Eldawoody HAF,Mattar MAB,Mesbah A,et al. Can brain natriuretic peptide,S100b,and interleukin-6 prognosticate the neurological consequences in Egyptian patients presented with supratentorial intracerebral hemorrhage?[J].Surg Neurol Int,2020,11:460.doi:10.25259/SNI_784_2020.eCollection 2020http://dx.doi.org/10.25259/SNI_784_2020.eCollection2020.
付永娟.不同病情程度基底节区HICH患者血清S100B、NSE水平变化及临床意义[J].江西医药,2021,56(8):1234-1236.doi:10.3969/j.issn.1006-2238.2021.08.048http://dx.doi.org/10.3969/j.issn.1006-2238.2021.08.048.
束梅燕,凌芸,杨淑娴,等.血清S100钙结合蛋白B水平对急性脑出血诊断及预后预测的价值[J].山东医药,2022,62(31):84-86.doi:10.3969/j.issn.1002-266X.2022.31.021http://dx.doi.org/10.3969/j.issn.1002-266X.2022.31.021.
宋永福,何升学,赵金兵,等.高血压性基底节区脑出血患者血清S100钙结合蛋白B、神经特异性烯醇化酶水平对病情的评估及预后的预测价值[J].临床神经病学杂志,2020,33(1):17-21.doi:10.3969/j.issn.1004-1648.2020.01.005http://dx.doi.org/10.3969/j.issn.1004-1648.2020.01.005.
张燕君,潘诗蕙,储伟.血清S-100β、NES和D-D水平与HICH术后转归的相关性研究[J].海南医学,2022,33(1):5-9.doi:10.3969/j.issn.1003-6350.2020.01.002http://dx.doi.org/10.3969/j.issn.1003-6350.2020.01.002.
Hwang BY,Appelboom G,Ayer A,et al.Advances in neuroprotective strategies:potential therapies for intracerebral hemorrhage[J].Cerebrovasc Dis,2011,31:211-222.doi:10.1159/000321870http://dx.doi.org/10.1159/000321870.
Zhao Z,Nelson AR,Betsholtz C,et al.Establishment and dysfunction of the blood-brain barrier[J].Cell,2015,163:1064-1078.doi:10.1016/j.cell.2015.10.067http://dx.doi.org/10.1016/j.cell.2015.10.067.
Simani L,Ramezani M,Mohammadi E,et al.Association of changed serum brain biomarkers with perihematomal edema and early clinical outcome in primary ICH patients[J].Neurologist,2022,27(4):168-172.doi:10.1097/NRL.0000000000000400http://dx.doi.org/10.1097/NRL.0000000000000400.
Mrozek S,Dumurgier J,Citerio G,et al.Biomarkers and acute brain injuries:interest and limits[J].Crit Care,2014,18:220.doi:10.1186/cc13841http://dx.doi.org/10.1186/cc13841.
Senn R,Elkind MS,Montaner J,et al.Potential role of blood biomarkers in the management of nontraumatic intracerebral hemorrhage[J].Cerebrovasc Dis,38(6):395-409.doi:10.1159/000366470http://dx.doi.org/10.1159/000366470.
Cordeiro JL,Neves JD,Nicola F,et al.Arundic acid (ONO-2506) attenuates neuroinflammation and prevents motor impairment in rats with intracerebral hemorrhage[J].Cell Mol Neurobiol,2022,42(3):739-751.doi:10.1007/s10571-020-00964-6http://dx.doi.org/10.1007/s10571-020-00964-6.
Glushakova OY,Glushakov AV,Miller ER,et al.Biomarkers for acute diagnosis and management of stroke in neurointensive care units[J].Brain Circ,2016,2(1):28-47.doi:10.4103/2394-8108.178546http://dx.doi.org/10.4103/2394-8108.178546.
0
Views
5
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
